.jpg)
Oslo Børs has revised the composition of the Benchmark Index (OSEBX). With effect from 1 June 2010, shares in 7 companies will be removed from the index, while 12 companies will be added to the index. The number of companies included in the index will be 58.
The Benchmark Index is intended to be an investable index that comprises a representative selection of all the shares listed on Oslo Børs. Since the index is meant to be investable, shares included in the index must be relatively easy to buy and sell in the market at any time.
The following companies will be removed from the index:
| Aker ASA |
| Blom ASA |
| Copeinca ASA |
| Mamut ASA |
| Norske Skogind. ASA |
| SAS AB |
| Veidekke ASA |
|
The following companies will be included in the index: Bakkafrost P/f |
| Clavis Pharma ASA |
| Eitzen Chemical ASA |
| Eltek ASA |
| Fornebu Utvikling ASA |
| Kongsberg Gruppen ASA |
| Nordic Semiconductor ASA |
| Nutri Pharma ASA |
| Odfjell Ser. A |
| Photocure ASA |
| Questerre Energy Corporation |
| Q-Free ASA |
The Oslo Børs Benchmark Index was introduced in 2001, and replaced the former total index. Since this time, the number of companies included in the Benchmark Index has varied between 52 and 81.
The next review of the Benchmark Index will be in November, with effect from 1 December 2010.
